Multiple Myeloma: Elranatamab Combination Therapy

We are studying a new treatment combination for patients with newly diagnosed multiple myeloma who cannot have a transplant. The goal is to see if it works better than a standard treatment option.

>2 years ≤5 visits Confirmation phase (III)No Placebo Cost Reimbursement Partially Remote Investigational Medicines Oral InjectionHematologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Darzalex

Darzalex is a medicine used to treat multiple myeloma, a type of blood cancer.

Human Normal Immunoglobulin Pharma Plasma

Human Normal Immunoglobulin Pharma Plasma is a medicine made from donated blood that provides antibodies to help prevent or treat immune system problems.

Nodexon

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Daratumumab

Daratumumab is a substance that helps treat multiple myeloma, a blood cancer, by directing the immune system to attack the cancerous plasma cells.

Dexamethasone

Dexamethasone is a steroid that reduces inflammation and suppresses the immune system to treat allergic, inflammatory, and autoimmune conditions.

Elranatamab

Elranatamab is an engineered antibody that helps the immune system target and kill cancerous plasma cells in multiple myeloma.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Privigen

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

7,5 Mg Stada

Amelinor

Axium

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Universitatsklinik für Innere Medizin Graz

Abteilung für Innere Medizin

Graz, Austria

Medizinische Universitaet Innsbruck

Abteilung für Innere Medizin

Innsbruck, Austria

Ordensklinikum Linz GmbH

Abteilung für Medizinische Hämatologie und Onkologie

Linz, Austria

Sponsor: Pfizer Inc.

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.